Skip to main content
Shanghai Labway Clinical Laboratory Co.,Ltd. logo

Shanghai Labway Clinical Laboratory Co.,Ltd. — Investor Relations & Filings

Ticker · 301060 ISIN · CNE100004RG8 Shenzhen Stock Exchange Human health and social work activities
Filings indexed 573 across all filing types
Latest filing 2026-05-29 Notice of Dividend Amou…
Country CN China
Listing Shenzhen Stock Exchange 301060

About Shanghai Labway Clinical Laboratory Co.,Ltd.

https://www.labway.cn

Shanghai Labway Clinical Laboratory Co., Ltd. is a third-party medical diagnostic service provider specializing in comprehensive clinical testing and pathology services. The company offers an extensive menu of diagnostic solutions, including molecular diagnostics, cytogenetics, immunology, and clinical chemistry, catering to hospitals, clinics, and health examination centers. Labway focuses on providing precise diagnostic data for oncology, infectious diseases, and genetic screening through the use of advanced automated laboratory systems. The organization maintains rigorous quality control standards, often adhering to ISO 15189 accreditation requirements, to ensure the accuracy and reliability of its results. By bridging the gap between clinical research and diagnostic application, the company supports healthcare providers with specialized testing and integrated health management services.

Recent filings

Filing Released Lang Actions
2025年年度权益分派实施公告
Notice of Dividend Amount Classification · 95% confidence The document is a corporate announcement by Shanghai Lanwei Medical Laboratory Co., Ltd. detailing the implementation of its 2025 annual equity distribution plan. It provides the dividend per share (RMB 1.80 per 10 shares), total dividend amount, record date, ex-dividend date, distribution methods, and tax treatment. This fits the definition of a Notice of Dividend Amount (DIV). It is not a general regulatory filing, earnings release, or proxy statement but specifically a dividend notice.
2026-05-29 Chinese
2025年年度股东会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 93% confidence The document is an announcement of the 2025 Annual General Meeting (AGM) resolutions, including detailed vote counts for each agenda item. It provides the official results of shareholder votes at an AGM. Therefore, it matches the “Declaration of Voting Results & Voting Rights Announcements” category (Code: DVA).
2026-05-22 Chinese
上海澄明则正律师事务所关于上海兰卫医学检验所股份有限公司2025年年度股东会的法律意见书
Regulatory Filings Classification · 65% confidence The document is a legal opinion letter (法律意见书) issued by a law firm on the legality of convening and conducting Shanghai Lanwei Medical Testing’s 2025 annual shareholders’ meeting. It contains no financial statements, earnings data, or proxy-solicitation cards but is a compliance/legal document submitted to the exchange. It does not match other specific categories (e.g., earnings release, AGM presentation, proxy solicitation, audit report). Therefore it falls into the fallback category for miscellaneous regulatory compliance filings: Regulatory Filings (RNS).
2026-05-22 Chinese
关于提请股东会授权董事会办理以简易程序向特定对象发行股票的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from Shanghai Lanwei Medical Laboratory Co., Ltd. regarding a proposal to the shareholders' meeting to authorize the board of directors to handle a simplified procedure for a private placement of shares to specific investors. It details the terms of the proposed share issuance, including the amount, pricing, target investors, use of proceeds, and authorization scope. The document is a formal announcement of a planned capital raising activity requiring shareholder approval, not the actual issuance or financial report. It does not contain financial statements or results but rather a proposal and authorization request related to capital financing. Therefore, it fits the category of Capital/Financing Update (CAP). The document length is 3219 characters, which is consistent with an announcement rather than a full report. Hence, the classification is CAP with high confidence.
2026-04-28 Chinese
2025年度董事会工作报告
Board/Management Information Classification · 95% confidence The document is titled '2025年度董事会工作报告' which translates to '2025 Annual Board of Directors Work Report'. It details the activities, meetings, and decisions of the company's board of directors throughout the year 2025. It includes information on board meetings, committee activities, governance, and plans for the next year. The content focuses on the board's work and governance rather than financial statements or audit results. It is not an annual report (10-K), audit report (AR), or earnings release (ER). It is not a regulatory filing or announcement of a report but a substantive report on board activities. Therefore, the document fits best under the category 'Board/Management Information' (MANG), which covers announcements of changes or reports related to the company's board or senior management activities. The document length (8301 characters) and detailed content support this classification with high confidence.
2026-04-28 Chinese
独立董事2025年度述职报告(裘国华)
Board/Management Information Classification · 95% confidence The document is titled as an "Independent Director 2025 Annual Work Report" for Shanghai Lanwei Medical Testing Co., Ltd. It is a detailed report by an independent director summarizing their duties, attendance, and activities during the 2025 fiscal year. The content includes descriptions of board meetings, committee participation, communication with auditors, oversight of internal controls, and evaluation of management appointments and remuneration. It is a formal report on the independent director's annual duties and performance rather than a general annual report or financial statement. This type of document fits best under the category of Board/Management Information (MANG), which covers announcements or reports related to board members and senior management activities. The document is not an annual report (10-K), audit report (AR), or any other category. The length and detail confirm it is a substantive report, not a brief announcement or certification. Therefore, the classification is MANG with high confidence.
2026-04-28 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.